SCHEMBL6672877

SCHEMBL6672877

COc1ccc(C(=O)CC(Cc2ccccc2)C(=O)O)cc1.COc1ccc(C(=O)CC(Cc2ccccc2)C(=O)O)cc1

nearest known ligand 0.75

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.60
RAB9A P51151 1/20 0.60
KMO O15229 1/20 0.59
PPARG P37231 2/20 0.57
PPARA Q07869 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
CPA1 P15085 3/20 0.55
CPB1 P15086 1/20 0.55
CPA3 P15088 1/20 0.55
CPB2 Q96IY4 1/20 0.55
TSHR P16473 1/20 0.54
LDHA P00338 1/20 0.54
CYP1A2 P05177 1/20 0.53
KMT2A Q03164 2/20 0.52
MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3101828 1.00 NPC1 (0.60) NPC1RAB9AKMOPPARGPPARA
SCHEMBL16284887 1.00 NPC1 (0.60) NPC1RAB9AKMOPPARGPPARA
SCHEMBL16284888 1.00 NPC1 (0.60) NPC1RAB9AKMOPPARGPPARA
SCHEMBL6675156 0.94 NPC1 (0.53) NPC1RAB9AKMOPPARGPPARA
SCHEMBL6672055 0.88 KMT2A (0.50) NPC1RAB9AKMOPPARGPPARA
SCHEMBL3104154 0.88 KMT2A (0.68) KMOPPARGPPARALDHAKMT2A
SCHEMBL3110072 0.88 LDHA (0.54) NPC1RAB9AKMOPPARGPPARA
SCHEMBL6674722 0.85 KMO (0.57) NPC1RAB9AKMOPPARGPPARA
SCHEMBL6177184 0.85 CYP1A2 (0.69) PPARGPPARACPA1CPB1CPA3
SCHEMBL3104186 0.85 TSHR (0.75) KMOCPA1CPB1CPA3CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458412-A1 PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A 4-OXOBUTANOIC ACID, AND THE USE THEREOF FOR TREATING DIABETES MERCK PATENT GmbH (DE) 2004-09-22 EP claimed
WO-2003055523-A1 PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A 4-OXOBUTANOIC ACID, AND THE USE THEREOF FOR TREATING DIABETES MERCK PATENT GMBH (DE) 2003-07-10 WO claimed